Published in Clin Biochem on March 01, 2005
VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology (2009) 1.47
Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis (2015) 1.22
Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J Gastroenterol (2009) 0.95
Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician (2007) 0.93
Genetic differences in oxidative stress and inflammatory responses to diet-induced obesity do not alter liver fibrosis in mice. Liver Int (2009) 0.90
What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.85
Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. J Nutr Biochem (2011) 0.83
Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Inflammation (2008) 0.83
Development of Fibrosis in Nonalcoholic Steatosis through Combination of a Synthetic Diet Rich in Disaccharide and Low-Dose Lipopolysaccharides in the Livers of Zucker (fa/fa) Rats. J Clin Biochem Nutr (2009) 0.82
The crude extract from puerariae flower exerts antiobesity and antifatty liver effects in high-fat diet-induced obese mice. Evid Based Complement Alternat Med (2012) 0.82
A silybin-phospholipids complex counteracts rat fatty liver degeneration and mitochondrial oxidative changes. World J Gastroenterol (2013) 0.79
Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome. Yonsei Med J (2016) 0.78
Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. J Diabetes Res (2015) 0.78
C-C chemokine receptor 2 inhibitor ameliorates hepatic steatosis by improving ER stress and inflammation in a type 2 diabetic mouse model. PLoS One (2015) 0.78
β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. J Inflamm Res (2014) 0.78
Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue. PLoS One (2015) 0.77
Genome-wide transcriptome expression in the liver of a mouse model of high carbohydrate diet-induced liver steatosis and its significance for the disease. Hepatol Int (2007) 0.76
Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells. World J Gastroenterol (2016) 0.75
Choline and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress Markers. Nutr Metab Insights (2015) 0.75
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Cholesterol gallstone disease. Lancet (2006) 2.83
Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology (2011) 2.67
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem (2007) 1.62
Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr Med Chem (2006) 1.60
Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem (2009) 1.50
Esomeprazole-induced central fever with severe myalgia. Ann Pharmacother (2005) 1.41
Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology (2008) 1.22
Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr (2006) 1.17
Primary sclerosing cholangitis: updates in diagnosis and therapy. World J Gastroenterol (2005) 1.16
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all. J Hepatol (2009) 1.12
The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors. Gastroenterology (2009) 1.08
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med (2012) 1.07
Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2 -mediated oxidative insult in H9C2 myocardial cells. Biochim Biophys Acta (2007) 1.06
Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta (2007) 1.05
The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res (2005) 1.05
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol (2003) 1.03
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. Wiley Interdiscip Rev Syst Biol Med (2011) 1.02
Bile acids and colon cancer: Solving the puzzle with nuclear receptors. Trends Mol Med (2011) 1.01
Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice. Gastroenterology (2013) 1.00
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol (2013) 0.99
Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease. Biochim Biophys Acta (2011) 0.96
Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J Gastroenterol (2009) 0.95
Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts. Clin Biochem (2007) 0.94
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. J Hepatol (2002) 0.93
Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician (2007) 0.93
Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine. Free Radic Biol Med (2005) 0.92
Rendu-Osler-Weber disease: experience with 56 patients. Ann Ital Med Int (2002) 0.91
Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis. Clin Sci (Lond) (2006) 0.91
Current pharmacological treatment of nonalcoholic fatty liver. Curr Med Chem (2006) 0.90
Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis. Expert Opin Biol Ther (2014) 0.89
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage. Dig Liver Dis (2009) 0.89
Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin Pharmacol Ther (2005) 0.89
Management of liver cirrhosis between primary care and specialists. World J Gastroenterol (2011) 0.89
Old and new antirheumatic drugs and the risk of hepatotoxicity. Ther Drug Monit (2012) 0.87
Non-alcoholic fatty liver disease in the metabolic syndrome. Curr Pharm Des (2007) 0.87
Contractility in vitro and mitochondrial response in small and large rabbit bowel after anastomosis. World J Surg (2002) 0.87
Avoiding drug interactions: here's help. J Fam Pract (2010) 0.87
Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder. Eur J Clin Invest (2013) 0.87
Contribution of canalicular glutathione efflux to bile formation. From cholestasis associated alterations to pharmacological intervention to modify bile flow. Curr Drug Targets Immune Endocr Metabol Disord (2005) 0.86
Nuclear receptors in regenerating liver and hepatocellular carcinoma. Mol Cell Endocrinol (2012) 0.86
Tolerability and safety profile of risperidone in a sample of children and adolescents. Int Clin Psychopharmacol (2013) 0.84
Dietary choline deprivation impairs rat brain mitochondrial function and behavioral phenotype. J Nutr (2010) 0.84
Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology (2007) 0.84
Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation. Curr Drug Targets Immune Endocr Metabol Disord (2003) 0.83
Transverse leukonychia in severe hypocalcemia. Eur J Dermatol (2004) 0.83
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes. Gastroenterology (2013) 0.82
T16189C mitochondrial DNA variant is associated with metabolic syndrome in Caucasian subjects. Nutrition (2010) 0.82
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants. Free Radic Biol Med (2007) 0.82
Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. World J Gastroenterol (2004) 0.82
Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats. Exp Gerontol (2004) 0.82
Therapeutic reflections in cholesterol homeostasis and gallstone disease: a review. Curr Med Chem (2014) 0.81
Quantitation of cholesterol crystallization from supersaturated model bile. J Lipid Res (2002) 0.81
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial). Adv Ther (2010) 0.80
Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis. Clin Exp Med (2013) 0.80
Basolateral Ca2+-dependent K+-channels play a key role in Cl- secretion induced by taurodeoxycholate from colon mucosa. Biol Cell (2003) 0.80
Surgically-induced bile duct injury is followed by early hepatic oxidative stress. A preliminary experimental study in rats. Hepatogastroenterology (2009) 0.80
Overview on the mechanisms of drug-induced liver cell death. Ann Hepatol (2004) 0.80
13C-breath tests for clinical investigation of liver mitochondrial function. Eur J Clin Invest (2010) 0.80
Noninvasive prediction of chronic atrophic gastritis in autoimmune thyroid disease in primary care. Scand J Gastroenterol (2014) 0.79
Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter study. Acta Radiol (2012) 0.79
Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program. J Gastrointestin Liver Dis (2008) 0.79
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury. ScientificWorldJournal (2012) 0.79
Metabolic syndrome: differences between psychiatric and internal medicine patients. Int J Psychiatry Med (2013) 0.79
Is it possible to predict the clinical course of gallstone disease? Usefulness of gallbladder motility evaluation in a clinical setting. Am J Gastroenterol (2006) 0.79
Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome. Biochim Biophys Acta (2013) 0.79
Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients. Clin Biochem (2011) 0.78
The emerging problem of nonalcoholic steatohepatitis (NASH). Rom J Gastroenterol (2005) 0.78
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. Eur J Dermatol (2012) 0.78
Assessing gastrointestinal symptoms and perception, quality of life, motility, and autonomic neuropathy in clinical studies. J Gastrointestin Liver Dis (2009) 0.78
Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents. Int Clin Psychopharmacol (2015) 0.78
Elderly residents at risk for being victims or offenders. J Am Med Dir Assoc (2012) 0.78
Water handling and aquaporins in bile formation: recent advances and research trends. J Hepatol (2003) 0.78
Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. Radiol Med (2015) 0.78
Ultrasonographic study of postcibal gastro-esophageal reflux and gastric emptying in infants with recurrent respiratory disease. World J Gastroenterol (2005) 0.78